Valuation: Viatris Inc.

Market Cap 21.19B 18.92B 17.45B 15.85B 29.74B 2,007B 30.2B 210B 82.81B 1,052B 79.54B 77.84B 3,332B P/E 2026 *
80.2x
P/E 2027 * 49.4x
Enterprise Value 33.14B 29.58B 27.29B 24.79B 46.51B 3,139B 47.23B 329B 130B 1,645B 124B 122B 5,210B EV / Sales 2026 *
2.24x
EV / Sales 2027 * 2.13x
Free-Float
91.44%
Yield 2026 *
2.75%
Yield 2027 * 2.82%
1 day+0.16%
1 week+1.43%
Current month+4.29%
1 month+7.57%
3 months+8.64%
6 months+27.27%
Current year+48.43%
1 week 18.18
Extreme 18.175
18.75
1 month 16.89
Extreme 16.89
18.75
Current year 12.19
Extreme 12.19
18.75
1 year 9.92
Extreme 9.92
18.75
3 years 6.85
Extreme 6.85
18.75
5 years 6.85
Extreme 6.85
18.75
10 years 6.85
Extreme 6.85
47.82
Manager TitleAgeSince
Chief Executive Officer 63 31/03/2023
Director of Finance/CFO 59 07/05/2026
Chief Tech/Sci/R&D Officer - 14/12/2023
Director TitleAgeSince
Director/Board Member 78 15/11/2020
Director/Board Member 78 15/11/2020
Director/Board Member 62 15/11/2020
Date Insider Type Main position Quantity % Market Cap. Importance
30/09/26 Free

Director

2,469 0.0002%
30/09/26 Free

Director

2,117 0.0002%
15/08/26 Exercice

Chief Administrative Officer

63,631 0.0054%
Change 5-day change 1-year change 3-year change Capi.($)
+0.16%+1.43%+77.52%+98.71% 21.19B
+2.83%+4.40%+60.84%+123.50% 1,165B
+3.81%+5.66%+38.70%+74.91% 645B
+0.14%+0.63%+24.71%+95.03% 504B
+0.03%+3.27%+39.79%+64.06% 380B
-1.76%+1.41%+68.06%+43.41% 363B
+1.58%+2.37%+22.91%+51.98% 297B
+2.90%+2.22%+3.51%+24.45% 269B
+2.04%+3.05%+51.12%+60.42% 237B
+2.36%-0.11%+29.42%+102.04% 195B
Average +1.59%+1.97%+41.66%+73.85% 407.67B
Weighted average by Cap. +1.97%+2.58%+43.02%+83.04%

Financials

2026 *2027 *
Net sales 14.78B 13.19B 12.17B 11.06B 20.74B 1,400B 21.06B 147B 57.76B 734B 55.48B 54.29B 2,324B 15.14B 13.51B 12.46B 11.32B 21.24B 1,434B 21.57B 150B 59.15B 751B 56.81B 55.6B 2,380B
Net income 142M 126M 117M 106M 199M 13.41B 202M 1.4B 553M 7.02B 531M 520M 22.25B 298M 266M 246M 223M 419M 28.27B 425M 2.96B 1.17B 14.81B 1.12B 1.1B 46.91B
Net Debt 11.95B 10.67B 9.84B 8.94B 16.77B 1,132B 17.03B 119B 46.69B 593B 44.85B 43.89B 1,878B 11.03B 9.85B 9.08B 8.25B 15.48B 1,045B 15.72B 109B 43.11B 547B 41.41B 40.52B 1,734B
Projected Income Statement - Annual - Viatris Inc.
Logo Viatris Inc.
Viatris Inc. is a global healthcare company. The Company markets branded and generic drugs, including complex drugs. The Company's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. Its Developed Markets segment comprises its operations primarily in North America and Europe. The Company's Greater China segment includes its operations in mainland China, Taiwan and Hong Kong. The Company's JANZ segment consists of its operations in Japan, Australia and New Zealand. Its Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies including in Asia, Africa, Eastern Europe, Latin America and the Middle East as well as the Company's ARV franchise. It produces medicines for patients across a broad range of major therapeutic areas. From cardiovascular health to oncology, it offers treatment options across more than 10 major therapeutic areas covering a variety of noncommunicable and infectious diseases.
Employees
30,000
Date Price Change Volume
22/10/26 US$18.48 +0.16% 5,435,601
21/10/26 US$18.45 -1.07% 10,188,700
20/10/26 US$18.65 +2.14% 14,265,693
19/10/26 US$18.26 -2.12% 11,529,423
16/10/26 US$18.66 +2.39% 9,422,361
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Viatris Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
18.48USD
Average target price
19.90USD
Spread / Average Target
+7.68%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Viatris Inc.
  1. Stock Market
  2. Stocks
  3. VTRS Stock